Prebona (PREBON) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Feb, 2026Executive summary
Revenue declined both in Q4 and for the full year 2025 compared to 2024, mainly due to delayed product launches and a weaker consumer market, especially in SurfaceCare.
Despite challenges, international expansion progressed with new distributors and customers in Asia, the Nordics, and the US.
HealthCare and AirCare segments showed strong momentum, with new contracts and product launches, while SurfaceCare began to recover late in the year.
The company enters 2026 with a stronger pipeline, expanded customer base, and improved commercial organization.
Financial highlights
Q4 2025 net sales: SEK 743,483 (down from SEK 1,122,754 in Q4 2024); full-year 2025 net sales: SEK 3,062,061 (down from SEK 5,677,931 in 2024).
Q4 2025 result after financial items: SEK -2,114,432 (Q4 2024: SEK -1,341,804); full-year 2025: SEK -7,861,126 (2024: SEK -7,206,545).
Q4 2025 cash flow from operations: SEK -739,836 (Q4 2024: SEK -2,242,521); full-year 2025: SEK -5,381,541 (2024: SEK -5,840,047).
Earnings per share Q4: SEK -0.06 (Q4 2024: SEK -0.05); full-year: SEK -0.23 (2024: SEK -0.25).
Number of shares at year-end: 34,060,803 (2024: 29,216,729).
Outlook and guidance
Order situation for 2026 indicates a more positive trend, with expected sales increases from ongoing activities and new product launches.
Management expects available liquidity, recent share issues, and new commitments to finance operations for the next 12 months; targeted strategic initiatives may require additional funding.
Latest events from Prebona
- Q3 2025 marked a turnaround with growth, improved results, and strong international expansion.PREBON
Q3 202527 Nov 2025 - Sales declined in Q2, but improved losses and new contracts signal expected recovery ahead.PREBON
Q2 202527 Aug 2025 - Sales improved in Q3, but losses persist as new launches and financing support future growth.PREBON
Q3 202413 Jun 2025 - Sales and earnings fell, but new products and financing position the company for future growth.PREBON
Q2 202413 Jun 2025 - Sales fell sharply in Q1, but HealthCare and AirCare segments showed strong growth potential.PREBON
Q1 20256 Jun 2025 - Sales fell but strategic wins and new funding position Prebona for future growth.PREBON
Q4 20246 Jun 2025